Bombardieri E - Search Results

1

A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group.

Bajetta E, Zilembo N, Barni S, Noberasco C, Martinetti A, Ferrari L, Schieppati G, Buzzoni R, Jirillo A, Amichetti M, D'Aprile M, Comella G, Bichisao E, Bolelli GF, Attili A, Bombardieri E. Bajetta E, et al. Among authors: bombardieri e. Ann Oncol. 1997 Jul;8(7):649-54. doi: 10.1023/a:1008270131789. Ann Oncol. 1997. PMID: 9296217 Free article. Clinical Trial.

2

The estrogen suppression after sequential treatment with formestane in advanced breast cancer patients.

Zilembo N, Bajetta E, Bichisao E, Martinetti A, La Torre I, Bidoli P, Longarini R, Portale T, Seregni E, Bombardieri E. Zilembo N, et al. Among authors: bombardieri e. Biomed Pharmacother. 2004 May;58(4):255-9. doi: 10.1016/j.biopha.2003.12.009. Biomed Pharmacother. 2004. PMID: 15183852 Clinical Trial.

3

Serum markers of bone metastases in postmenopausal breast cancer patients treated with formestane.

Martinetti A, Bajetta E, Seregni E, Zilembo N, Ferrari L, Noberasco C, Massaron S, Rimassa L, Bombardieri E. Martinetti A, et al. Among authors: bombardieri e. Tumour Biol. 1997;18(4):197-205. doi: 10.1159/000218030. Tumour Biol. 1997. PMID: 9218004

4

Development of a rapid and ultrasensitive RIA method for estrogen (E2, E1, E1-S) determination with selective solid phase extraction.

Martinetti A, Seregni E, Bajetta E, Bolelli GF, Ferrari L, Massaron S, Botti C, Bombardieri E. Martinetti A, et al. Among authors: bombardieri e. Int J Biol Markers. 1997 Jul-Sep;12(3):102-5. Int J Biol Markers. 1997. PMID: 9479591

5

Premenopausal breast cancer patients treated with a gonadotropin-releasing hormone analog alone or in combination with an aromatase inhibitor: a comparative endocrine study.

Celio L, Martinetti A, Ferrari L, Buzzoni R, Mariani L, Miceli R, Seregni E, Procopio G, Cassata A, Bombardieri E, Bajetta E. Celio L, et al. Among authors: bombardieri e. Anticancer Res. 1999 May-Jun;19(3B):2261-8. Anticancer Res. 1999. PMID: 10472341 Clinical Trial.

6

The luteinising hormone-releasing hormone analogue triptorelin with or without the aromatase inhibitor formestane in premenopausal breast cancer: effects on bone metabolism markers.

Martinetti A, Ferrari L, Celio L, Mariani L, Miceli R, Zilembo N, Di Bartolomeo M, Toffolatti L, Pozzi P, Seregni E, Bombardieri E, Bajetta E. Martinetti A, et al. Among authors: bombardieri e. J Steroid Biochem Mol Biol. 2000 Dec 1;75(1):65-73. doi: 10.1016/s0960-0760(00)00138-2. J Steroid Biochem Mol Biol. 2000. PMID: 11179910 Clinical Trial.

7

Efficacy of a chemotherapy combination for the treatment of metastatic neuroendocrine tumours.

Bajetta E, Ferrari L, Procopio G, Catena L, Ferrario E, Martinetti A, Di Bartolomeo M, Buzzoni R, Celio L, Vitali M, Beretta E, Seregni E, Bombardieri E. Bajetta E, et al. Among authors: bombardieri e. Ann Oncol. 2002 Apr;13(4):614-21. doi: 10.1093/annonc/mdf064. Ann Oncol. 2002. PMID: 12056713 Free article. Clinical Trial.

8

Biological activity of anastrozole in postmenopausal patients with advanced breast cancer: effects on estrogens and bone metabolism.

Bajetta E, Martinetti A, Zilembo N, Pozzi P, La Torre I, Ferrari L, Seregni E, Longarini R, Salvucci G, Bombardieri E. Bajetta E, et al. Among authors: bombardieri e. Ann Oncol. 2002 Jul;13(7):1059-66. doi: 10.1093/annonc/mdf083. Ann Oncol. 2002. PMID: 12176784 Free article.

9

Effects of aromatase complex selective inhibition on insulin-like growth factor 1 and insulin-like growth factor binding protein 3 circulating levels in breast cancer.

Ferrari L, Bajetta E, Seregni E, Martinetti A, Zilembo N, Noberasco C, Buzzoni R, Botti C, Massaron S, Bichisao E, Celio L, Bombardieri E. Ferrari L, et al. Among authors: bombardieri e. Int J Oncol. 1997 Jul;11(1):163-7. doi: 10.3892/ijo.11.1.163. Int J Oncol. 1997. PMID: 21528196

10

Could exemestane affect insulin-like growth factors, interleukin 6 and bone metabolism in postmenopausal advanced breast cancer patients after failure on aminoglutethimide, anastrozole or letrozole?

Ferrari L, Bajetta E, Martinetti A, Celio L, Longarini R, La Torre I, Buzzoni R, Gattinoni L, Seregni E, Bombardieri E. Ferrari L, et al. Among authors: bombardieri e. Int J Oncol. 2003 May;22(5):1081-9. Int J Oncol. 2003. PMID: 12684675

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters